Association of Vitamin C with Enhanced Prognosis in Patients Experiencing Myocardial Injury Due to Sepsis: Findings from the MIMIC-IV Database - Takeaways - MDSpire

Association of Vitamin C with Enhanced Prognosis in Patients Experiencing Myocardial Injury Due to Sepsis: Findings from the MIMIC-IV Database

  • By

  • Rui Gong

  • Zifeng Huang

  • Jinyi Zhao

  • Meng Tang

  • Fei Mu

  • Kexin Sun

  • Chen Cui

  • Zhen Yan

  • Jingwen Wang

  • December 24, 2025

  • 0 min

Share

  • 1

    Sepsis-induced myocardial injury (SIMI) has a high mortality rate, with in-hospital mortality around 35% and up to 51% within one year.

  • 2

    Vitamin C (VC) shows potential as an adjunctive therapy for SIMI, with previous studies indicating it may improve organ function and reduce mortality.

  • 3

    The study utilized the MIMIC-IV database to investigate the effects of VC on the prognosis of patients with SIMI.

  • 4

    Existing research on VC's efficacy in sepsis has produced mixed results, highlighting the need for targeted studies on SIMI patients.

  • 5

    Understanding VC's role in SIMI could lead to improved management strategies for this high-risk patient population.

Original Source(s)

Association of Vitamin C with Enhanced Prognosis in Patients Experiencing Myocardial Injury Due to Sepsis: Findings from the MIMIC-IV Database

  • by Rui Gong, Zifeng Huang, Jinyi Zhao, Meng Tang, Fei Mu, Kexin Sun, Chen Cui, Zhen Yan, Jingwen Wang

  • December 24, 2025

Related Content

Association between baseline-stratified trajectory subgroups of serum albumin and outcomes in critically ill patients with early sepsis-associated acute kidney injury: a retrospective study

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.

Autophagy–ferroptosis crosstalk in sepsis: metabolic pathways, redox injury, and host-directed antioxidant nanomedicine